Academy of Integrative Medicine, Biomedical Research Center, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China.
Oncology Department of The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350004, P.R. China.
Mol Med Rep. 2017 Nov;16(5):7752-7758. doi: 10.3892/mmr.2017.7500. Epub 2017 Sep 18.
Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive tract, and threatens the survival and health of patients with CRC. Chemotherapy remains one of the main therapeutic approaches for patients with CRC; however, drug resistance limits the long‑term use. CRC cells with multi‑drug resistance (MDR) exhibit increased survival times and metastatic potential, which may lead to the recurrence and metastasis of CRC. In addition, MDR is one of the major causes of chemotherapy failure in clinical treatment. Hedyotis diffusa Willd (HDW) has been used in the treatment of inflammation‑associated diseases and malignant tumors, including CRC. The authors previously demonstrated that HDW could reverse MDR in CRC cells; however, its underlying mechanism, particularly in MDR‑associated metastasis, remains to be elucidated. In the present study, the drug‑resistant CRC cell line HCT‑8/5‑fluorouracil (5‑FU) was used to investigate the effect of HDW on the growth and metastasis of cancer cells. Cell viability was assessed using the MTT assay. Cell adhesion potential was evaluated using adhesion experiments. Cell migration was assessed using wound healing and Transwell assays. The mRNA and protein expression levels of crucial factors in the transforming growth factor‑β (TGF‑β) signaling pathway, including TGF‑β, Mothers against decapentaplegic homolog 4 (SMAD4), neural (N)‑cadherin, and epithelial (E)‑cadherin, were analyzed using the reverse transcription‑semi‑quantitative polymerase chain reaction and western blotting, respectively. The results demonstrated that the HCT‑8/5‑FU cell line was more resistant to 5‑FU and thus can be used as the resistant cell model. HDW was able to inhibit the viability, and adhesive, migratory and invasion potential of the HCT‑8/5‑FU cells. In addition, HDW was able to downregulate the expression of TGF‑β, SMAD4 and N‑cadherin, and upregulate E‑cadherin, at the gene and protein level. In conclusion, the results demonstrated that HDW may suppress the metastasis of 5‑FU‑resistant CRC cells via regulation of the TGF‑β signaling pathway, which was also considered to be one of the underlying mechanisms of its anti‑CRC effect.
结直肠癌(CRC)是最常见的消化道恶性肿瘤之一,威胁着 CRC 患者的生存和健康。化疗仍然是 CRC 患者的主要治疗方法之一;然而,耐药性限制了其长期使用。具有多药耐药性(MDR)的 CRC 细胞表现出存活时间延长和转移潜能增加的特征,这可能导致 CRC 的复发和转移。此外,MDR 是临床治疗中化疗失败的主要原因之一。白花蛇舌草(HDW)已被用于治疗炎症相关疾病和恶性肿瘤,包括 CRC。作者先前证明,HDW 可逆转 CRC 细胞的 MDR;然而,其潜在机制,特别是在与 MDR 相关的转移中,仍有待阐明。在本研究中,使用耐药性 CRC 细胞系 HCT-8/5-氟尿嘧啶(5-FU)来研究 HDW 对癌细胞生长和转移的影响。使用 MTT 法评估细胞活力。通过粘附实验评估细胞粘附潜力。通过划痕愈合和 Transwell 实验评估细胞迁移。使用逆转录-半定量聚合酶链反应和蛋白质印迹法分别分析转化生长因子-β(TGF-β)信号通路中关键因子的 mRNA 和蛋白表达水平,包括 TGF-β、Mothers against decapentaplegic homolog 4(SMAD4)、神经(N)-钙粘蛋白和上皮(E)-钙粘蛋白。结果表明,HCT-8/5-FU 细胞系对 5-FU 的耐药性更高,因此可用作耐药细胞模型。HDW 能够抑制 HCT-8/5-FU 细胞的活力以及粘附、迁移和侵袭能力。此外,HDW 能够下调 TGF-β、SMAD4 和 N-钙粘蛋白的表达,并上调基因和蛋白水平的 E-钙粘蛋白。综上所述,结果表明,HDW 可能通过调节 TGF-β 信号通路抑制 5-FU 耐药 CRC 细胞的转移,这也被认为是其抗 CRC 作用的潜在机制之一。